FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024862214> ?p ?o ?g. }

• W2024862214 endingPage "659" @default.
• W2024862214 startingPage "650" @default.
• W2024862214 abstract "Heat-shock protein 990 (HSP990) is a potent and selective synthetic small-molecule HSP90 inhibitor. The primary objectives of this phase I first-in-human study were to determine dose-limiting toxicities (DLTs), maximum-tolerated dose (MTD) and recommended phase II dose (RP2D). Secondary objectives included characterisation of the safety profile, pharmacokinetics (PKs) and pharmacodynamics (PDs).Heat-shock protein 990 was administered orally once or two times weekly on a 28-day cycle schedule in patients with advanced solid tumours. Dose escalation was guided by a Bayesian logistic regression model with overdose control.A total of 64 patients were enrolled. Fifty-three patients received HSP990 once weekly at 2.5, 5, 10, 20, 30, 50 or 60 mg, whereas 11 patients received HSP990 two times weekly at 25 mg. Median duration of exposure was 8 weeks (range 1-116 weeks) and 12 patients remained on treatment for >16 weeks. Dose-limiting toxicities occurred in seven patients and included diarrhoea, QTc prolongation, ALT/AST elevations and central neurological toxicities. The most common drug-related adverse events were diarrhoea, fatigue and decreased appetite. Further dose escalation beyond 60 mg once weekly was not possible owing to neurological toxicity. Rapid absorption, no drug accumulation and large interpatient variability in PK exposures were observed. No objective responses were seen; 25 patients had a best overall response of stable disease.Heat-shock protein 990 is relatively well tolerated, with neurological toxicity being the most relevant DLT. The single agent MTD/RP2D of HSP990 was declared at 50 mg once weekly." @default.
• W2024862214 created "2016-06-24" @default.
• W2024862214 creator A5000204204 @default.
• W2024862214 creator A5011364353 @default.
• W2024862214 creator A5019036811 @default.
• W2024862214 creator A5033615082 @default.
• W2024862214 creator A5033987639 @default.
• W2024862214 creator A5036495404 @default.
• W2024862214 creator A5041145711 @default.
• W2024862214 creator A5045084904 @default.
• W2024862214 creator A5046458113 @default.
• W2024862214 creator A5049131973 @default.
• W2024862214 creator A5066784644 @default.
• W2024862214 creator A5086060519 @default.
• W2024862214 creator A5088186975 @default.
• W2024862214 date "2015-01-27" @default.
• W2024862214 modified "2023-10-18" @default.
• W2024862214 title "A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies" @default.
• W2024862214 cites W1691798915 @default.
• W2024862214 cites W1971190195 @default.
• W2024862214 cites W1990001284 @default.
• W2024862214 cites W1992189987 @default.
• W2024862214 cites W1997113115 @default.
• W2024862214 cites W1999410266 @default.
• W2024862214 cites W2002834238 @default.
• W2024862214 cites W2006979847 @default.
• W2024862214 cites W2014537095 @default.
• W2024862214 cites W2016976719 @default.
• W2024862214 cites W2018514409 @default.
• W2024862214 cites W2021227263 @default.
• W2024862214 cites W2022531767 @default.
• W2024862214 cites W2026888844 @default.
• W2024862214 cites W2031152262 @default.
• W2024862214 cites W2043472262 @default.
• W2024862214 cites W2045985885 @default.
• W2024862214 cites W2049250459 @default.
• W2024862214 cites W2050529682 @default.
• W2024862214 cites W2082568045 @default.
• W2024862214 cites W2088942787 @default.
• W2024862214 cites W2089353069 @default.
• W2024862214 cites W2095231417 @default.
• W2024862214 cites W2096721687 @default.
• W2024862214 cites W2097995306 @default.
• W2024862214 cites W2100214216 @default.
• W2024862214 cites W2100541925 @default.
• W2024862214 cites W2102673471 @default.
• W2024862214 cites W2104209550 @default.
• W2024862214 cites W2105747169 @default.
• W2024862214 cites W2108732005 @default.
• W2024862214 cites W2109387315 @default.
• W2024862214 cites W2111069189 @default.
• W2024862214 cites W2111644529 @default.
• W2024862214 cites W2115204449 @default.
• W2024862214 cites W2129053473 @default.
• W2024862214 cites W2131728593 @default.
• W2024862214 cites W2133688312 @default.
• W2024862214 cites W2136245016 @default.
• W2024862214 cites W2137374006 @default.
• W2024862214 cites W2145759876 @default.
• W2024862214 cites W2147277119 @default.
• W2024862214 cites W2147423147 @default.
• W2024862214 cites W2147873672 @default.
• W2024862214 cites W2149344761 @default.
• W2024862214 cites W2152086706 @default.
• W2024862214 cites W2157769714 @default.
• W2024862214 cites W2162554249 @default.
• W2024862214 cites W2163541635 @default.
• W2024862214 cites W2166191023 @default.
• W2024862214 cites W2170573493 @default.
• W2024862214 cites W2527444926 @default.
• W2024862214 cites W2590111539 @default.
• W2024862214 cites W4210407906 @default.
• W2024862214 cites W4249825500 @default.
• W2024862214 doi "https://doi.org/10.1038/bjc.2014.653" @default.
• W2024862214 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4333497" @default.
• W2024862214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25625276" @default.
• W2024862214 hasPublicationYear "2015" @default.
• W2024862214 type Work @default.
• W2024862214 sameAs 2024862214 @default.
• W2024862214 citedByCount "31" @default.
• W2024862214 countsByYear W20248622142015 @default.
• W2024862214 countsByYear W20248622142016 @default.
• W2024862214 countsByYear W20248622142017 @default.
• W2024862214 countsByYear W20248622142018 @default.
• W2024862214 countsByYear W20248622142019 @default.
• W2024862214 countsByYear W20248622142020 @default.
• W2024862214 countsByYear W20248622142021 @default.
• W2024862214 countsByYear W20248622142022 @default.
• W2024862214 countsByYear W20248622142023 @default.
• W2024862214 crossrefType "journal-article" @default.
• W2024862214 hasAuthorship W2024862214A5000204204 @default.
• W2024862214 hasAuthorship W2024862214A5011364353 @default.
• W2024862214 hasAuthorship W2024862214A5019036811 @default.
• W2024862214 hasAuthorship W2024862214A5033615082 @default.
• W2024862214 hasAuthorship W2024862214A5033987639 @default.
• W2024862214 hasAuthorship W2024862214A5036495404 @default.
• W2024862214 hasAuthorship W2024862214A5041145711 @default.
• W2024862214 hasAuthorship W2024862214A5045084904 @default.

• next